 nyse
figur may add due round
compani descript base parsippani new jersey zoeti
develop manufactur market pharmaceut
livestock companion anim
compani also offer diagnost product genom servic
servic custom primarili includ livestock
farmer veterinarian pet owner compani
product aid healthcar cat dog equin swine beef
dairi cattl sheep poultri fish
adjust estim tax reform
tax reform impact zoeti announc tax reform
expect caus million less charg
benefit come form effect tax rate
previous estim
effect tax rate
updat estim oper ep estim
unchang ep estim
lower loss conserv assum full
million charg profit previous
increas non- ep
estim stand previous
non-gaap ep estim
valuat zoeti close yesterday trail
oper ep next twelv month oper
ep estim determin price target took
averag forward price-to-earnings seen sinc effici initi
announc incorpor dcf model
recogn impress cash flow gener appli
multipl non-gaap ep
estim deriv price target use
unchang wacc two-stag growth model
free cash flow equiti calcul price target
use two-stag growth model due confid
intermedi outlook compani howev
think would aggress use growth rate
use five year beyond estim
perpetu thu second stage growth rate assumpt
conserv weight price-to-earnings
methodolog heavili moment due
linger uncertainti around full impact tax reform
previous use equal weight thu deriv
price target reiter buy rate
note import disclosur page
note analyst certif page
zoeti well diversifi term product custom base geographi compani industri
attract secular growth profil companion anim segment recession-resist
opinion howev compani livestock custom base subject commod cycl zoeti
limit histori publicli trade compani fairli lever final view compani
statu growth stock anoth risk consid given factor suitabl rate
depend livestock industri zoeti deriv signific amount revenu custom
associ agricultur industri subject mani factor beyond control
weather diseas outbreak
chang consum attitud companion anim busi depend consum
continu view pet member famili treat accordingli chang
attitud could halt human pet harm zoeti outlook addit lower consumpt
anim protein could hurt zoeti custom therebi reduc demand zoeti product
competit anim health busi highli competit attract signific capit
new competitor innov new product solut competitor could displac zoeti
integr acquisit zoeti fairli acquisit throughout histori
anticip continu failur success integr acquisit could lead financi result
expect
failur and/or new product zoeti also intern develop new product product
line failur success develop sell new product could harm profit
legal product lawsuit common health care sector unfavor court decis could
hamper abil market product whether current patent zoeti success challeng
zoeti determin infring upon patent competitor
regulatori zoeti product must go variou regulatori agenc approv
companion anim market could undergo signific shift new regul introduc
regard veterinari prescript practic side busi livestock industri
also subject signific regulatori requir oversight situat creat uncertainti
zoeti custom
emerg market exposur zoeti deriv signific portion revenu
emerg market market tend riskier due polit econom and/or currenc
addit inform avail upon request
kurt kemper herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
